Cutting edge: both activating and inhibitory Fc receptors expressed on mast cells regulate experimental allergic

Michaela Robbie-Ryan1, Melinda B Tanzola, Virginia H Secor

  • 1Graduate Program in Immunology and Molecular Pathogenesis, Emory University School of Medicine, Atlanta, GA 30322, USA.

Insights

Mast cells significantly impact experimental allergic encephalomyelitis (EAE) severity. Activating and inhibitory Fc receptors (FcRs) on mast cells modulate EAE, influencing disease course and symptoms in this multiple sclerosis model.

Area of Science:

  • Immunology
  • Neuroscience
  • Cell Biology

Background:

  • Mast cells play a role in autoimmune diseases like multiple sclerosis.
  • Experimental allergic encephalomyelitis (EAE) is a mouse model used to study multiple sclerosis.
  • Fc receptors (FcRs) on mast cells are involved in immune responses.

Purpose of the Study:

  • To investigate the role of Fc receptor-mediated mast cell activation in EAE.
  • To determine how different FcRs on mast cells affect the severity and course of EAE.

Main Methods:

  • Mast cell-deficient mice (W/W(v)) were reconstituted with bone marrow-derived mast cells (BMMCs) lacking specific FcRs.
  • EAE was induced in reconstituted mice using myelin oligodendrocyte glycoprotein peptide.
  • Clinical disease scores were analyzed and compared between groups.

Main Results:

  • Mice reconstituted with FcRgamma or FcgammaRIII deficient BMMCs showed reduced EAE severity.
  • Mice reconstituted with FcRIIB deficient BMMCs exhibited exacerbated EAE.
  • FcgammaRIII deficiency in BMMCs led to a relapsing-remitting EAE course.

Conclusions:

  • Both activating and inhibitory FcRs on mast cells are critical in modulating EAE.
  • Mast cell FcRs represent potential therapeutic targets for multiple sclerosis.